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Abstract 
The effects of alcohol have been widely studied during 
the past century, corroborating the idea that this tiny 
chemical compound acts throughout most of our 
neurotransmitter systems since it is capable of inducing 
addictive behaviour.  
Two of the most serious problems of alcohol addiction 
are craving and relapse; several studies have demonstrated 
that relapse is related to the anxious state which occurs 
during withdrawal, and it has been proved that this 
behavioural modifications results from an alteration of the 
dopaminergic and serotonergic systems. An important role 
in the neurobiology of alcohol addiction is played by 
acetaldehyde (ACD), ethanol first metabolite.  
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Our recent studies indeed, have demonstrated that 
ACD itself is able to induce CRH release from 
hypothalamic explants, underlying the central role 
played by ACD in alcohol-induced modifications of 
the HPA axis. Moreover, for the first time, this group 
has shown that ACD is able to induce and maintain an 
operant drinking behaviour after repeated abstinence 
periods, and in the presence of a conflict situation in 
rats, mimicking the same characteristics as alcohol. 
ACD is produced either peripherally or within the 
brain by alcohol dehydrogenase and catalase, 
respectively. Studies assert that the highest 
concentrations of catalase in the brain are mainly 
located in aminergic neurons suggesting that ACD 
could take part in alcohol action in those circuitries. 
Further investigations are then necessary to fully 
understand the molecular mechanisms underlying the 
neurochemical and behavioural modifications induced 
by ACD, as a mediator of alcohol activity in the brain. 
 
 Introduction 
Today alcohol addiction is one of the most serious 
clinical and socioeconomic problems for many 
countries. Excessive drinking is a social emergency, 
especially if we look at young people; in fact in 
Europe, from 1998 to 2010, alcohol consumption 
among adolescents, aged between 14 and 20 years old, 
increased from 12.6% to 20.5%. It is not a controlled 
use of alcohol that must be criminalized, but its abuse, 
and the reason for that is the establishment of an 
addictive behaviour. As for other substances of abuse, 
alcohol addiction is a chronic relapsing brain disorder, 
characterized by neurobiological changes, leading to 
compulsive drug seeking and drug taking despite 
serious negative consequences, and by loss of control 
over drug use. The neuronal networks supporting the 
compulsive consumption of alcohol are the circuitries 
responsible for the positive reinforcement, which is to 
say the activation of the dopaminergic neurons of the 
ventral tegmental area (VTA) which project to the 
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nucleus accumbens (NAC), where an increase in dopamine 
release (DA) occurs.  
  
EtOH Effect on the self-administration Paradigm  
One commonly used approach for modelling human 
alcohol consumption in rodents is the free-access paradigm 
with alcohol at various strength, where the amount of each 
fluid consumed is measured. Usually, at the beginning, rats 
prefer alcohol solutions of lower concentrations (<6%), 
because of their “sweet taste”, over those of higher 
concentration 1. With this aim our research group has 
recently published a study which sought to examine 
ethanol intake and preference patterns in heterogeneous 
adult male Wistar rats, using a 3-bottle choice paradigm 
with water, 10%-ethanol solution, and white wine (10% 
v/v),  for a four-week period.  
Our results showed that during the three-bottle choice 
paradigm, adult male rats displayed an initial 47% 
alcoholic preference that decreased to a final 24% in the 
last two weeks. 
Rat drinking patterns displayed an irregular trend, 
including dramatic peaks in the early days, followed by 
sharp drops in the following days. This irregular pattern 
may resemble the initial binge-like drinking behaviour 
observed in humans, as a function of the rewarding effects 
exerted by alcohol; this was then followed by a voluntary, 
and probably necessary, reduction in alcohol intake in 
order to recover from intoxication. It seems therefore, that 
rats with alcohol free-access (AFA) are able to control 
their alcoholic intake in order to avoid unpleasant effects, 
but enjoyed the reinforcing properties of alcohol. 
When the animals were tested in the Morris water 
maze in order to assess the acquisition of spatial learning 
and memory tasks, interestingly, alcohol induced a 
facilitatory effect just in a task that required a new 
processing of spatial information. It was then hypothesized 
that AFA, was able to enhance spatial flexibility, when an 
unexpected change in the environment required an 
adaptive response in order to find a solution. 
When female rats were exposed to the same 
experimental conditions, they drank more alcohol than 
males during the paradigm, reaching a preference of 55%. 
This pattern can be explained through the activation of the 
mesolimbic dopaminergic reward system, since it is 
reported that female rats display a greater release of 
dopamine in the NAcc following alcohol consumption 
when compared to males.2 
When exposed to the MWM, in order to assess the 
effects of alcohol self-administration on learning and 
memory abilities, female rats showed a significant 
worsening with respect to control rats together with a 
significant decrease in both locomotor activity and 
explorative behaviour in the open field. It is widely 
reported that women tend to suffer from alcohol-related 
physical illness and display more severe cognitive and 
motor impairments compared to men. Whether the 
effects observed in our study are related to metabolic 
or to pharmacodynamic mechanisms is difficult to say, 
but the topic is worth further investigation. 
 
Alcoholism or Acetaldehydism? 
Several studies in the last 30 years have 
investigated the role and the effects of acetaldehyde 
(ACD) as one of the mediators of the central and 
peripheral effects of ethanol. ACD derives from the 
peripheral metabolism of ethanol (EtOH) by alcohol-
dehydrogenase (ADH) and is converted into acetic 
acid by aldehyde dehydrogenase (ALDH). Traditional 
views contend that acetaldehyde is an "aversive" 
compound responsible for the so-called "flushing 
syndrome", which is exploited therapeutically by 
disulfiram.3,4 A slow but measurable accumulation of 
ACD in the rat brain has also been demonstrated. 
Although other enzymes from the microsomal ethanol-
oxidizing system (MEOS) such as CYP2E1, and 
alcohol dehydrogenase I (ADH I) are also present in 
the brain,5,6 but to a lesser extent than in the 
periphery,; the biochemical data suggest that 
acetaldehyde is formed in the brain mainly by catalase, 
when ethanol is administered acutely.7,8 However, in 
sharp contrast with the idea of a toxic metabolite, 
recent data suggest that acetaldehyde is actually 
rewarding both in rodents and humans.9 Particularly, 
acetaldehyde induces "place preference";10 it is self-
administered directly in the VTA area;9,11 and acts as 
other crucial cellular elements of drug-induced 
reward.12,13 
 
ACD and  neuropeptides 
The opioidergic system modulates some of the 
mechanisms which are at the base of the induction and 
the maintenance of addiction. Some experiments 
conducted on hypothalamic neuronal cultures have 
demonstrated that ACD stimulates, more than EtOH, 
the release of beta-endorphin.14 Interestingly, when the 
enzymatic oxidation of EtOH into ACD is blocked by 
the inhibition of cerebral catalase, beta-endorphin 
release is inhibited, suggesting that EtOH effects could 
be mediated by its conversion into ACD.15 Stress 
mediators, released by the activation of the 
hypothalamus-pituitary-adrenal (HPA) axis, are 
involved in setting up alcohol addiction.16 EtOH 
administration activates the HPA axis, and therefore 
releases ACTH and glucocorticoids17,18 through the 
stimulation of the paraventricular nucleus of the 
hypothalamus.19 Recent data of our group demonstrate 
indeed that EtOH is able to stimulate CRF release 
from hypothalamic explants and that this effect is 
mediated by ACD. To validate this hypothesis we 
showed that ACD was able to stimulate CRH release 
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in a dose-dependent manner. When the hypothalamic 
oxidation of EtOH into ACD by cerebral catalase was 
inhibited by 3amino-1,2,4-triazole, this compound in the 
presence of EtOH completely prevented hypothalamic 
CRF release. Furthermore, the administration of D-
penicillamine, an ACD- trapping agent, inhibited ACD-
induced CRF release, demonstrating that ACD was the 
primary mediator of EtOH activity on the HPA axis. In 
conclusion, the repeated consumption of EtOH induces, 
through the formation of ACD, a rearrangement of 
neurotransmitter and peptidergic circuitries that contribute 
to the onset and the maintenance of alcohol addiction. 
 
ACD and self-administration 
It is still under debate whether, under physiological 
conditions, acetaldehyde formed in the liver is able to 
penetrate into the brain from the periphery because of the 
metabolic barrier presented by ALDH in the blood–brain 
barrier.20 Studies showing central effects of peripherally 
administered ACD seem to validate this possibility.21,22 
 Self-administration, within operant conditioning, is 
considered a valid experimental model to investigate drug-
seeking and drug-taking behaviour in rats: the higher the 
frequency of the animal response, the more rewarding and 
possibly addictive, the test substance.23 Although 
dopamine was originally proposed to mediate 
“reward”,24,25 recent studies indicate that dopamine is 
likely to have a more general role in the processing of 
behaviourally relevant positive and negative stimuli and 
the selection of appropriate responding.26-28 Addiction 
induces or modifies complex behavioural and 
neurobiological processes, including the different stimuli 
which lead to relapse. Indeed, more than 80% of addicts 
relapse to drug seeking and use after a period of 
withdrawal and abstinence. Understanding the 
neurobiological basis of drug seeking and relapse, 
following the deprivation effect, is a central issue of the 
research on addiction.29 
With this aim we recently wished to evaluate: whether 
oral ACD could induce a self-administration behaviour in 
an operant conditioning paradigm; hence its reinforcing 
properties on the maintenance of this behaviour; and the 
induction of a relapse behaviour upon the introduction of 
repeated deprivation phases. Our results showed that ACD, 
was able to induce an operant drinking behaviour 
according to a FR-1 schedule, and moreover ACD-
drinking rats displayed a higher number of lever presses 
and greater amount of volume ingested, when compared to 
water-drinking rats.30 Drug self-administration is directly 
under rat control, and the frequency and amount of drug 
self-administration are widely used to infer drug hedonic 
properties: positively reinforcing drugs will be readily and 
avidly self-administrated. Though explored according to 
other experimental paradigms, ACD reinforcing properties 
have already been reported in other research employing a 
self-administration pattern of consumption.9,31,32 Those 
studies showed that ACD self administration is easier 
to establish than ethanol self-administration,33 
indicating that ACD is a stronger reinforcer than its 
parent drug ethanol, whatever the route of 
administration, systemic or central. On the other hand, 
it has been suggested that ACD is able to cross the 
blood–brain barrier after a single systemic 
administration.34 Moreover when ACD-deprived rats 
underwent a re-presentation of ACD, and their ACD 
intake over baseline drinking was measured, in 
accordance with evidence of increased alcohol 
consumption following periods of abstinence, ACD-
drinking rats displayed a higher number of lever 
presses and a significant increase in liquid intake 
compared to controls. Moreover when ACD intake 
during the different relapse sessions was compared to 
basal ACD intake, a significant effect of deprivation 
was recorded. Interestingly, ACD intake in the second 
and third week of relapse was significantly higher then 
in the first week. The increase in ACD intake might be 
caused by an increase in the reinforcing value of ACD; 
alternatively ACD itself may be acting as a cue or as a 
priming stimulus, as reported with alcohol. The 
alcohol deprivation effect in long-term voluntary 
alcohol drinking rats is used as a measure of craving; 
i.e. high motivation to drink alcohol as a measure for 
relapse-like behaviour.35 Therefore, these findings 
suggest a motivated operant drinking behaviour which 
reflects an incentive demand for the drug, apart from 
any other possible reason than motivation. 
 
ACD and motivation 
In contrast to experimental models involving 
spontaneous, threatening stimuli, in the Geller-Seifter 
procedure rats suffer from the “conflict” between the 
drive to drink and the fear of the shock: this usually 
leads to a suppression of a conditioned response for 
reinforcement. Punishment-based procedures have 
been thus employed for the identification and 
characterization of the anti-conflict properties of 
several drugs, including ethanol.36 Here we report the 
observation of the effects of ACD in a modification of 
the Geller-Seifter procedure, where a negative 
reinforcer was introduced in the operant behaviour so 
that together with ACD solution, a mild electric foot-
shock was elicited following each lever press (in 
press).  
The presentation of the aversive stimulus, in the 
CTR group, had a dissuasive effect, and led to a 
dramatic decrease in the number of punished responses, 
according to the principles of behavioral psychology.37 
In ACD-drinking rats, instead, such a reduction was 
not observed, and the number of punished responses 
was significantly augmented. Usually, the unpunished 
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component of the test is poorly interested by the anxiolytic 
activity of the drugs unless when high doses are employed 
causing sedation and motor in coordination that is 
responsible for the decrease in the unpunished responses. 
In our study ACD was also able to increase the unpunished 
responses, although at a lesser extent than the punished 
ones. This was against a lack of effect on locomotor 
activity as resulted by the experiments in the open field. 
Therefore the effects exerted by ACD in increasing both 
the punished and the unpunished responses might be due 
to a prevalent motivational effect. 
Studies based on the use of ADH- or ALDH inhibitors, 
of catalase inhibitors, or of ACD- sequestering agents, 
have consistently shown that the effects of ethanol on 
locomotor activity anxiety HPA axis activation and 
motivation appear to be mediated by ACD. The 
modulation of alcohol-derived ACD, either by reducing its 
production and ⁄ or by using sequestrating agents, may 
exert a profound influence on the reinforcing and 
discriminative effects of alcohol, and might also accelerate 
the development of more effective therapeutic 
interventions to reduce the incidence of alcohol abuse and 
alcoholism. 
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